Treo Ventures

Treo Ventures is a venture capital firm established in 2018, focusing on early-stage investments in healthcare companies, particularly in medical devices and diagnostics. The firm operates through offices in Santa Clara, California, and Dublin, Ireland, targeting significant unmet needs in the healthcare sector.

The firm's investment strategy emphasizes medical device and digital health innovation with substantial clinical impact. Treo Ventures has invested globally in over 65 companies across multiple market cycles, leveraging a team with more than 90 years of cumulative healthcare experience in investing and operational roles.

Treo Ventures' portfolio includes companies such as InterVene, Inc., a clinical-stage medical device company developing ultrasound-based treatments for inflammatory disorders; Neuspera Medical, Inc., committed to developing implantable medical device technology for chronic illnesses; and CVRx®, a leader in innovative technologies addressing unmet needs in cardiovascular diseases. The firm's approach combines deep industry knowledge with a commitment to advancing healthcare solutions that improve patient outcomes.